HMGA2: A pituitary tumour subtype-specific oncogene?

被引:58
作者
Fedele, Monica [1 ]
Palmieri, Dario [1 ]
Fusco, Alfredo [1 ]
机构
[1] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, CNR, IEOS, Naples, Italy
关键词
High Mobility Group proteins; Pituitary adenomas; cell cycle; transgenic mice; RB/E2F; cyclin B2; PULMONARY CHONDROID HAMARTOMAS; GROUP PROTEIN GENE; MOBILITY GROUP A2; BENIGN MESENCHYMAL TUMORS; SQUAMOUS-CELL CARCINOMA; NATURAL-KILLER-CELL; EXPRESS HIGH-LEVELS; TRANSGENIC MICE; HMGI(Y) PROTEIN; C GENE;
D O I
10.1016/j.mce.2010.03.019
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The high mobility group AT-hook (HMGA) proteins, a family of DNA architectural factors, are highly expressed during embryogenesis and play a crucial role in several different biological processes, as well as in tumorigenesis of a wide range of tissues, including pituitary. Indeed, HMGA2 has been found rearranged and amplified in human prolactinomas, and transgenic mice overexpressing either Hmga1 or Hmga2 develop pituitary adenomas secreting prolactin and growth hormone. Here, we overview HMGA proteins in human tumours, focusing on pituitary adenomas and the mechanisms by which the HMGA proteins are involved in their onset and development. Different HMGA-dependent potential drives of pituitary oncogenesis are discussed as future research directions in the field. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 98 条
[1]  
Abe N, 1999, CANCER RES, V59, P1169
[2]  
Abe N, 2000, CANCER RES, V60, P3117
[3]   Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas [J].
Abe, N ;
Watanabe, T ;
Izumisato, Y ;
Masaki, T ;
Mori, T ;
Sugiyama, M ;
Chiappetta, G ;
Fusco, A ;
Fujioka, Y ;
Atomi, Y .
PANCREAS, 2002, 25 (02) :198-204
[4]  
ANDERSEN B, 1994, J BIOL CHEM, V269, P29335
[5]   Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas [J].
Arlotta, P ;
Tai, AKF ;
Manfioletti, G ;
Clifford, C ;
Jay, G ;
Ono, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14394-14400
[6]   Cytokine expression and molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth [J].
Arzt, E ;
Pereda, MP ;
Costas, M ;
Sauer, J ;
Renner, U ;
Holsboer, F ;
Stalla, GK .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :525-531
[7]   INTERLEUKIN-2 AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN HUMAN CORTICOTROPIC ADENOMA AND MURINE PITUITARY CELL-CULTURES [J].
ARZT, E ;
STELZER, G ;
RENNER, U ;
LANGE, M ;
MULLER, OA ;
STALLA, GK .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1944-1951
[8]   CELL-TYPE-SPECIFIC EXPRESSION OF THE PITUITARY TRANSCRIPTION ACTIVATOR PIT-1 IN THE HUMAN PITUITARY AND PITUITARY-ADENOMAS [J].
ASA, SL ;
PUY, LA ;
LEW, AM ;
SUNDMARK, VC ;
ELSHOLTZ, HP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1275-1280
[9]  
ASHAR HR, 1995, CELL, V82, P57
[10]   HMGI(Y) gene expression in colorectal cancer:: Comparison with some histological typing, grading, and clinical staging [J].
Balcerczak, M ;
Pasz-Walczak, G ;
Balcerczak, E ;
Wojtylak, M ;
Kordek, R ;
Mirowski, M .
PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (10) :641-646